The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The FDA has notified health professionals that Chantix, a smoking cessation product, has been associated with erratic behavior in patients. Some patients reported suicidal thoughts and aggressive behavior within days or weeks of taking Chantix. The FDA is reviewing the cases. For more information about Chantix, view this page.

For more information on this subject, please see our section on Drugs, Medical Devices and Implants.

Comments are closed.

Of Interest